Both the WT and Col18a1–/– female mice that received WT-PyMT tumor cells developed palpable tumors by week 7 after implantation (Figure 5D), but these grew faster in the WT hosts, reaching the humane endpoint size limit, on average 550 mm3, by week 10. This evidence concerns the gene COL18A1 and neoplasm.